Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
08/27/1991 | US5043331 Kit; uninterrupted oral daily dose of estrogen and progestogen compounds for 90 day period; prevents endometrial hyperplasiz and osteoporosis |
08/27/1991 | US5043330 Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them |
08/27/1991 | US5043328 Formulations containing unsaturated fatty acids for the synthesis of prostaglandins and hydroxy-fatty acids in biological systems |
08/27/1991 | US5043326 Inclusion complex of 7-isopropoxy-isoflavon formed with cyclodextrin, the preparation thereof and pharmaceutical compositions containing these compounds as active ingredients |
08/27/1991 | US5043325 N-6 substituted adenosine derivatives as cardiac vasodilators |
08/27/1991 | US5043324 Macrolide compounds |
08/27/1991 | US5043323 Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them |
08/27/1991 | US5043273 Phosphorylated glycosidase inhibitor prodrugs |
08/27/1991 | US5043168 Nonhygroscopic, antiarthritis agent, analgesic |
08/27/1991 | US5043167 Galenic formulations with programmed release |
08/27/1991 | CA2073450A1 Cycloalkyl-substituted glutaramide antihypertensive agents |
08/27/1991 | CA2053873A1 Quinolone derivatives |
08/27/1991 | CA2037123A1 Substituted ethylamines, their process of preparation, their use as medication and their synthetic intermediates |
08/27/1991 | CA2036964A1 Method of antiviral enhancement |
08/27/1991 | CA2036960A1 Novel synthesis of carbapenem intermediates |
08/27/1991 | CA2036417A1 Quinoline and pyridine anchors for hmg-coa reductase inhibitors |
08/27/1991 | CA2035711A1 3-arylcarbonyl-1-(c-attached-n-heteryl)-1h-indoles |
08/27/1991 | CA2035265A1 Process for preparing ¬1s-¬1.alpha.,2.alpha.(z), 3.alpha.,4.alpha.||-7-¬3-¬¬¬¬(1-oxoheptyl)-amino|-acetyl|amino|methyl|- |
08/27/1991 | CA2011045A1 Immunosuppressant |
08/27/1991 | CA1288107C Leukotriene antagonists |
08/27/1991 | CA1288102C Pyridine derivatives, their preparation and their use |
08/27/1991 | CA1288101C Aromatic w-alkylimino-tetrahydro-6h-1,3-thiazin-6-one derivatives |
08/27/1991 | CA1288100C 1-(hydroxymethyl)-1,6,7,11b-tetrahydro-2h,4h-[1,3]- oxazino- or thiazino-[4,5-a]-isoquinoline derivatives, process for their preparation and pharmaceutical compositions containingthem |
08/27/1991 | CA1288098C 4-(guanin-9-yl)butanals and their 3-oxa, 3-thia and 2-ene derivatives having antiviral and antitumor activity |
08/27/1991 | CA1288091C 6-.beta.(SUBSTITUTED)-(S)-HYDROXYMETHYLPENICILLANIC ACIDS AND DERIVATIVES THEREOF |
08/27/1991 | CA1288050C Nitrofurantoin dosage form |
08/27/1991 | CA1288049C Sustained release capsule or tablet formulation |
08/27/1991 | CA1288048C Aqueous steroid formulations for nasal administration |
08/27/1991 | CA1288045C Apparatus and process for oxygenation of liquid state dissolved oxygen-carrying formulation |
08/24/1991 | WO1991012815A1 COMPOSITIONS AND METHODS FOR TREATING INFECTIONS CAUSED BY ORGANISMS SENSITIVE TO β-LACTAM ANTIBIOTICS |
08/24/1991 | CA2076529A1 Compositions and methods for treating infections caused by organisms sensitive to beta-lactam antibiotics |
08/24/1991 | CA2036941A1 Carbapenem derivatives having antibiotic activity, their preparation and their use |
08/24/1991 | CA2036912A1 Diamine derivatives and their use in oncology |
08/24/1991 | CA2036902A1 Hypoglycemic agents |
08/23/1991 | WO1991012804A1 New use |
08/23/1991 | CA2036847A1 Steroid products containing a spiro radical in position 17; process for preparing the same and intermediates for this process; their use as t erapeutic agents and |
08/23/1991 | CA2036846A1 Lactic acid acylates and their salts; process for preparing the same and compositions containing them |
08/23/1991 | CA2036774A1 Method of reducing serum uric acid and/or increasing renal uric acid clearance with thromboxane synthetase inhibitor and/or thromboxane receptorantagonist or a |
08/22/1991 | WO1991012253A1 Tetralin and chroman derivatives useful in the treatment of asthma, arthritis, and related diseases |
08/22/1991 | WO1991012247A1 Nitrogen-containing cyclohetero cycloalkylaminoaryl derivatives for cns disorders |
08/22/1991 | WO1991012239A1 HOMOLOGATED VITAMIN D2 COMPOUNDS AND THE CORRESPONDING 1α-HYDROXYLATED DERIVATIVES |
08/22/1991 | WO1991012238A1 Side-chain-homologous vitamin d derivatives, process for producing them, pharmaceutical preparations containing these derivatives and their use as medicaments |
08/22/1991 | WO1991012235A1 Allosteric hemoglobin modifiers |
08/22/1991 | WO1991012230A1 Nitric acid esters of cyclohexanol derivatives |
08/22/1991 | WO1991012026A1 Means of reducing surgical adhesions |
08/22/1991 | WO1991012021A2 Therapeutic agents, and intermediates for the synthesis thereof |
08/22/1991 | WO1991012011A1 Novel anti-tumoral agent derived from dextran |
08/22/1991 | WO1991012007A1 Method of treating pre-menstrual syndrome |
08/22/1991 | WO1991012005A1 Neuroprotective 3-piperidino-4-hydroxychroman derivatives and analogs |
08/22/1991 | WO1991012004A1 Topical use of 6-n-butyl-1,4,7,10-tetrahydro-4,10-dioxo-1,7-phenanthroline-2,8-dicarboxylic acid derivatives |
08/22/1991 | WO1991011996A1 Hydroquinone amino-acid esters, method of preparation, and pharmaceutical or cosmetic compositions containing them |
08/22/1991 | WO1991011995A1 Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties |
08/22/1991 | WO1991011994A1 Inhibitor of denatured ldl formation |
08/22/1991 | WO1991011988A1 Alternative enzyme substrates as deodorants |
08/22/1991 | WO1991011918A1 Docosahexaenoic acid, methods for its production and compounds containing the same |
08/22/1991 | DE4005371A1 New N-(hetero)aryl-substd. 2-piperidino:ethyl oxazolidinone derivs. |
08/22/1991 | DE4005275A1 Verwendung von s-adenosylmethionin als mittel gegen virale infektionen durch retroviren Use of S-adenosylmethionine as an agent against viral infections by retroviruses |
08/22/1991 | DE4005159A1 Use of new and known sugar-substd. di:terpene(s) - as immuno:modulator(s), esp. for stimulating T-cells |
08/22/1991 | DE4004978A1 Preventing therapy for Alzheimer's disease - comprises administering synthetic complexing agent with higher affinity for aluminium ions than ATP and citrate ions |
08/22/1991 | DE4004841A1 Salpetersaeureester von cyclohexanol-derivaten Salpetersaeureester of cyclohexanol derivatives |
08/22/1991 | CA2076012A1 Agent for inhibiting the formation of denatured ldl |
08/22/1991 | CA2075988A1 Nitric acid esters of cyclohexanol derivatives |
08/22/1991 | CA2058637A1 Side-chain homologous vitamin d derivatives, process for their production, pharmaceutical preparations containing these derivatives and their use as pharmaceutical agents |
08/22/1991 | CA2036708A1 Use of a dihydropyridine compound |
08/22/1991 | CA2036589A1 2,4,8-trisubstituted-3h-6h-1,4,5a,8a-tetraazaacenaphthylene -3,5-(4h)-diones |
08/22/1991 | CA2036586A1 Oxazolidinones |
08/21/1991 | WO1991012809A1 Use of s-adenosyl methionine as an agent against viral infections by retroviruses |
08/21/1991 | WO1991012801A1 Compositions containing green porphyrins to destroy malignant cells in mononuclear cell populations |
08/21/1991 | EP0442850A1 Esters of acyl L-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of coma |
08/21/1991 | EP0442820A1 Benzimidazole and azabenzimidazole derivatives, thromboxane receptor antagonists, processes for their preparation, synthesis intermediates, compositions containing them |
08/21/1991 | EP0442783A1 Elfamycin compound, process for its preparation and its use |
08/21/1991 | EP0442757A2 Therapeutic nucleosides |
08/21/1991 | EP0442748A1 Improvements in and relating to leukotriene antagonists |
08/21/1991 | EP0442744A2 Treatment of viral disease by glycosides |
08/21/1991 | EP0442663A1 Improvements in chemical compounds |
08/21/1991 | EP0442537A1 A mental disease therapeutic agent |
08/21/1991 | EP0442424A1 Treatment of sleep apneas with azapirone derivatives |
08/21/1991 | EP0442423A1 Use of buspirone in sleep apneas |
08/21/1991 | EP0442385A2 Process for de preparation of 7-amino-3-methoxymethyl-ceph-3-em-4-carboxylic acid |
08/21/1991 | EP0442378A1 Selective processes for fosinopril polymorphs |
08/21/1991 | EP0442350A1 Medical preparation containing stigmasta-4-en-3-one and the use thereof |
08/21/1991 | EP0442348A2 Imidazole compounds, process for preparation, medicaments based on these compounds and some intermediates |
08/21/1991 | EP0442204A2 Pyrimidopyrimidine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them |
08/21/1991 | EP0442141A1 Pharmaceutical preparation |
08/21/1991 | EP0442140A1 Dietetic food for patients with renal insufficiency |
08/21/1991 | EP0442063A2 Use of 2',4',6'-trimethoxy-4-(1-pyrrolidinyl) butyrophenone for the topical treatment of trophic diseases |
08/21/1991 | EP0442012A1 Sustained release compositions containing valproic acid |
08/21/1991 | EP0409910A4 Laminated composite for transdermal administration of fentanyl |
08/21/1991 | EP0237538B1 Retardation preparation for a medicine |
08/21/1991 | EP0117872B1 Process for preparing cephalosporin compounds |
08/21/1991 | CN1053923A Neuroprotective 3-piperidino-4-hydroxychroman derivatives |
08/21/1991 | CN1053919A Imidazole compounds, their preparing process and pharmaceutical based of compounds and some intermediums |
08/21/1991 | CN1053889A Process for preparing medicine-qingxin oil for curing pustuloderma |
08/21/1991 | CN1013547B Process for preparing solid products containing oil soluble material |
08/21/1991 | CA2076377A1 Use of s-adenosyl methionine as an agent against viral infections by retroviruses |
08/21/1991 | CA2036678A1 Pharmaceutical compositions having depigmentating and antiphotoageing activity |
08/21/1991 | CA2036629A1 Phospholipides based pharmaceutical compositions |
08/20/1991 | WO1991012265A1 N-phenyl n-alkoxycarbonylalkyl glycinamides, preparation method and drugs containing them |
08/20/1991 | WO1991012246A1 Novel 4-methyl thiazole derivatives, preparation methods therefor and pharmaceutical compositions containing said derivatives |
08/20/1991 | WO1991011997A1 Maillard reaction inhibitor |